PB-1902

N/A

Report date: 2024/05/21 14:28:05
NME

Base Information

Drug NamePB-1902
Drug Alias NamePB-1902
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor antagonists
TargetsMu opioid receptor
Therapy Area/IndicationsGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPeg Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPeg Bio Co Ltd
Inactive CompaniesN/A
Active IndicationsGastrointestinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A